Biography
Professional Summary
Education & Certifications
- Fellowship: Stanford University School of Medicine (1993) CA
- Residency: Stanford University School of Medicine (1990) CA
- Internship: Stanford University School of Medicine (1988) CA
- Board Certification: American Board of Internal Medicine, Infectious Disease (1994)
- Medical Education: University Of Virginia (1987) VA
- BA, Stanford University, Biological Sciences (1981)
- MD, University of Virginia, Hypoxemic myocardial injury (1987)
- Residency, Stanford University, Internal Medicine (1990)
- Fellowship, Stanford University, Infectious Diseases (1996)
Publications
-
Immunity to infections following hematopoietic cell transplantation
Brown, J. M., Weissman, I. L., & Shizuru, J. A. (2001). Immunity to infections following hematopoietic cell transplantation. CURRENT OPINION IN IMMUNOLOGY, 13(4), 451–457. -
Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation
Bitmansour, A., & Brown, J. M. Y. (2002). Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation. JOURNAL OF INFECTIOUS DISEASES, 186(1), 134–37. -
Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation
Bitmansour, A., Burns, S. M., Traver, D., Akashi, K., Contag, C. H., Weissman, I. L., & Brown, J. M. Y. (2002). Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. BLOOD, 100(13), 4660–67. -
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation
Arber, C., Bitmansour, A., Sparer, T. E., Higgins, J. P., Mocarski, E. S., Weissman, I. L., … Brown, J. M. Y. (2003). Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. BLOOD, 102(2), 421–28. -
Fungal infections in bone marrow transplant patients
Brown, J. M. Y. (2004). Fungal infections in bone marrow transplant patients. CURRENT OPINION IN INFECTIOUS DISEASES, 17(4), 347–52. -
Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia
Bitmansour, A., Cao, T. M., Chao, S., Shashidhar, S., & Brown, J. M. Y. (2005). Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. BLOOD, 105(9), 3535–37. -
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
Johnston, L. J., Brown, J., Shizuru, J. A., Stockerl-Goldstein, K. E., Stuart, M. J., Blume, K. G., … Chao, N. J. (2005). Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 11(1), 47–55. -
The influence of the conditions of hematopoietic cell transplantation on infectious complications
Brown, J. M. Y. (2005). The influence of the conditions of hematopoietic cell transplantation on infectious complications. CURRENT OPINION IN INFECTIOUS DISEASES, 18(4), 346–51. -
Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective
Brown, J. M. Y. (2005). Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective. CURRENT OPINION IN INFECTIOUS DISEASES, 18(4), 352–58. -
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation
Dvorak, C. C., Steinbach, W. J., Brown, J. M. Y., & Agarwal, R. (2005). Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 36(7), 621–29. -
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination
Noda, S., Aguirre, S. A., Bitmansour, A., Brown, J. M., Sparer, T. E., Huang, J., & Mocarski, E. S. (2006). Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. BLOOD, 107(1), 30–38. -
Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus
Garcia-Ojeda, M. E., Dejbakhsh-Jones, S., Chatterjea-Matthes, D., Mukhopadhyay, A., Bitmansour, A., Weissman, I. L., … Strober, S. (2005). Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. JOURNAL OF IMMUNOLOGY, 175(7), 4363–73. -
Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted
Arber, C., Bitmansour, A., Shashidhar, S., Wang, S., Tseng, B., & Brown, J. M. Y. (2005). Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. JOURNAL OF INFECTIOUS DISEASES. SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: UNIV CHICAGO PRESS. -
Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature
Cha, S., Johnston, L., Natkunam, Y., & Brown, J. (2005). Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature. TRANSPLANT INFECTIOUS DISEASE, 7(3-4), 158–61. -
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation
Nguyen, V. H., Shashidhar, S., Chang, D. S., Ho, L., Kambham, N., Bachmann, M., … Negrin, R. S. (2008). The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. BLOOD, 111(2), 945–53. -
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
Wloch, M. K., Smith, L. R., Boutsaboualoy, S., Reyes, L., Han, C., Kehler, J., … Boeckh, M. (2008). Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. JOURNAL OF INFECTIOUS DISEASES, 197(12), 1634–42. -
Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation
Vana, M. L., Formankova, D., Cha, S., Sharma, A., Potena, L., Brown, J. M. Y., & Mocarski, E. S. (2008). Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. CLINICAL INFECTIOUS DISEASES, 47(4), 535–39. -
Utility of Influenza Vaccination for Oncology Patients
Pollyea, D. A., Brown, J. M. Y., & Horning, S. J. (2010). Utility of Influenza Vaccination for Oncology Patients. JOURNAL OF CLINICAL ONCOLOGY, 28(14), 2481–90. -
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY
Naik, S., Wong, R., Arai, S., Brown, J., Laport, G., Lowsky, R., … Johnston, L. (2011). Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. BONE MARROW TRANSPLANTATION, 46(2), 192–99. -
A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy
Sokolove, J., Copland, A., Shirvani, S., Brown, J., Posley, K., & Chung, L. (2010). A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy. ARTHRITIS CARE & RESEARCH, 62(9), 1351–56. -
Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients
Kim, J. H., Schaenman, J. M., Ho, D. Y., & Brown, J. M. Y. (2011). Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(2), 259–64. -
Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation
Chung, B., Min, D., Joo, L. W., Krampf, M. R., Huang, J., Yang, Y., … Weinberg, K. I. (2011). Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(1), 48–60. -
Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative Hematopoietic Cell Transplantation with a Total Lymphoid Irradiation and Antithymocyte Globulin Preparative Regimen
Schaenman, J. M., Shashidhar, S., Rhee, C., Wong, J., Navato, S., Wong, R. M., … Brown, J. M. (2011). Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative Hematopoietic Cell Transplantation with a Total Lymphoid Irradiation and Antithymocyte Globulin Preparative Regimen. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(5), 693–702. -
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
Johnston, L., Florek, M., Armstrong, R., McCune, J. S., Arai, S., Brown, J., … Negrin, R. (2012). Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 47(4), 581–88. -
Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity
Mueller, A. M. S., Shashidhar, S., Kuepper, N. J., Kohrt, H. E. K., Florek, M., Negrin, R. S., … Shizuru, J. A. (2012). Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(15), 5820–25. -
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
Arai, S., Sahaf, B., Narasimhan, B., Chen, G. L., Jones, C. D., Lowsky, R., … Miklos, D. B. (2012). Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. BLOOD, 119(25), 6145–54. -
SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE ESCHERICHIA-COLI GUANOSINE PHOSPHORIBOSYL TRANSFERASE (GPT) GENE
Greaves, R. F., Brown, J. M., VIEIRA, J., & Mocarski, E. S. (1995). SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE ESCHERICHIA-COLI GUANOSINE PHOSPHORIBOSYL TRANSFERASE (GPT) GENE. JOURNAL OF GENERAL VIROLOGY, 76, 2151–60. -
DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE
Brown, J. M., Kaneshima, H., & Mocarski, E. S. (1995). DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE. JOURNAL OF INFECTIOUS DISEASES, 171(6), 1599–1603. -
Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome
Mocarski, E. S., Prichard, M. N., TAN, C. S., & Brown, J. M. (1997). Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. VIROLOGY, 239(1), 169–75. -
Neutropenic mice can be protected from fungus infection by ex vivo expanded allogeneic myeloid progenitors.
Domen, J., Wahedi, M., Danenberg, E., Smith-Berdan, S., Christensen, J., Fong, T., & Brown, J. (2005). Neutropenic mice can be protected from fungus infection by ex vivo expanded allogeneic myeloid progenitors. BLOOD. ATLANTA,GA,GA,GA,GA,GA,GA: AMER SOC HEMATOLOGY. -
Adoptively Transferred Mature T Cells Exhibit Diminished Reactivity to Murine Cytomegalovirus Compared to Nascent Donor T Cells and Impair Functional Immune Recovery After Allogeneic Hematopoietic Cell Transplantation
Mueller, A. M. S., Shashidhar, S., Brown, J., & Shizuru, J. A. (2010). Adoptively Transferred Mature T Cells Exhibit Diminished Reactivity to Murine Cytomegalovirus Compared to Nascent Donor T Cells and Impair Functional Immune Recovery After Allogeneic Hematopoietic Cell Transplantation. BLOOD. ORLANDO,FL,FL,FL,FL,FL,FL: AMER SOC HEMATOLOGY. -
Graft T Cells Retard Stem Cell Derived Lymphoid Organ Reconstitution and Immune Function After Allogeneic Transplantation
Mueller, A. M. S., Kohrt, H. E., Shashidhar, S., Florek, M., Kuepper, N. J., Brown, J. (W. M., & Shizuru, J. A. (2011). Graft T Cells Retard Stem Cell Derived Lymphoid Organ Reconstitution and Immune Function After Allogeneic Transplantation. BLOOD, 118(21), 1722–22. -
Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results in Low Chronic Gvhd
Arai, S., Sahaf, B., Jones, C., Zhender, J., Lowsky, R., Strober, S., … Miklos, D. (2008). Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results in Low Chronic Gvhd. BLOOD. SAN FRANCISCO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC HEMATOLOGY. -
Rituximab infusion two months after nonmyeloablative transplantation maintains B-cell disease control with minimal GVHD.
Arai, S., Sahaf, B., Jones, C., Zehnder, J., Lowsky, R., Strober, S., … Miklos, D. (2006). Rituximab infusion two months after nonmyeloablative transplantation maintains B-cell disease control with minimal GVHD. BLOOD. ORLANDO,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL: AMER SOC HEMATOLOGY. -
Increased transplant-related mortality following high-dose sequential chemotherapy and autologous hematopoietic cell transplantation (AHCT) using the Ceprate SC stem cell concentration system for multiple myeloma (MM).
Stockerl-Goldstein, K. E., Brown, J. M., O'Brien, R. M., Negrin, R. S., Hu, W. W., JOHNSTON, L. J., … Blume, K. G. (1999). Increased transplant-related mortality following high-dose sequential chemotherapy and autologous hematopoietic cell transplantation (AHCT) using the Ceprate SC stem cell concentration system for multiple myeloma (MM). BLOOD, 94(10), 608A–608A. -
Regulation of common lymphoid progenitors (CLP) by common gamma (gamma(C)) and C-kit signals in vivo.
Dudl, E., Toyama, A., Arber, C., Bitmansour, A., Brown, J., Chung, B., … Weinberg, K. I. (2003). Regulation of common lymphoid progenitors (CLP) by common gamma (gamma(C)) and C-kit signals in vivo. BLOOD. SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC HEMATOLOGY. -
Functional Control of CMV Reactivation Is Profoundly Influenced by CMV Serostatus after Nonmyeloablative Hematopoietic Cell Transplantation Following a TLI-ATG Preparative Regimen
Schaenman, J., Vana, M. L., Rhee, C., Wong, J., Navato, S., Johnston, L. J., … Brown, J. (W. (2008). Functional Control of CMV Reactivation Is Profoundly Influenced by CMV Serostatus after Nonmyeloablative Hematopoietic Cell Transplantation Following a TLI-ATG Preparative Regimen. BLOOD. SAN FRANCISCO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC HEMATOLOGY. -
Enhanced immune reconstitution and function by CD4+CD25+ regulatory T cells following allogeneic hematopoietic cell transplantation.
Nguyen, V. H., Shashidhar, S., Zeiser, R., Ho, L., Brown, J. M. Y., & Negrin, R. S. (2005). Enhanced immune reconstitution and function by CD4+CD25+ regulatory T cells following allogeneic hematopoietic cell transplantation. BLOOD, 106(11), 23A–23A. -
CD4+CD25+ Regulatory T cells enhance immune reconstitution following allogeneic hematopoietic cell transplantation by protecting thymic and lymphoid compartments from graft-versus-host disease damage without impacting T cell repertoire development.
Nguyen, V. H., Chang, D., Shashidhar, S., Bachmann, M., Contag, C. H., Brown, J. M. Y., & Negrin, R. S. (2006). CD4+CD25+ Regulatory T cells enhance immune reconstitution following allogeneic hematopoietic cell transplantation by protecting thymic and lymphoid compartments from graft-versus-host disease damage without impacting T cell repertoire development. BLOOD, 108(11), 25A–25A. -
Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001-2006
Park, B. J., Pappas, P. G., Wannemuehler, K. A., Alexander, B. D., Anaissie, E. J., Andes, D. R., … Kontoyiannis, D. P. (2011). Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001-2006. EMERGING INFECTIOUS DISEASES, 17(10), 1855–64. -
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., … Pappas, P. G. (2010). Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. CLINICAL INFECTIOUS DISEASES, 50(8), 1091–1100. -
Successful Surgical and Medical Treatment of Rhizopus Osteomyelitis Following Hematopoietic Cell Transplantation
Vashi, N., Avedian, R., Brown, J., & Arai, S. (2012). Successful Surgical and Medical Treatment of Rhizopus Osteomyelitis Following Hematopoietic Cell Transplantation. ORTHOPEDICS, 35(10), E1556–E1561. -
Gastrointestinal Mucormycosis Initially Manifest as Hematochezia from Arterio-Enteric Fistula
Cloyd, J. M., Brown, J., Sinclair, T., Jenks, D., Desai, J., Longacre, T., … Shelton, A. (2014). Gastrointestinal Mucormycosis Initially Manifest as Hematochezia from Arterio-Enteric Fistula. DIGESTIVE DISEASES AND SCIENCES, 59(12), 2905–8. -
Peritoneal Coccidioidomycosis: a Rare Case Report and Review of the Literature
Storage, T. R., Segal, J., & Brown, J. (2015). Peritoneal Coccidioidomycosis: a Rare Case Report and Review of the Literature. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 24(4), 527–30. -
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Marty, F. M., Ostrosky-Zeichner, L., Cornely, O. A., Mullane, K. M., Perfect, J. R., Thompson, G. R., … Vehreschild, M. J. G. T. (2016). Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. LANCET INFECTIOUS DISEASES, 16(7), 828–37. -
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors
Young, J.-A. H., Logan, B. R., Wu, J., Wingard, J. R., Weisdorf, D. J., Mudrick, C., … Anasetti, C. (2016). Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(2), 359–70. -
Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.
Epstein, D. J., Seo, S. K., Brown, J. M., & Papanicolaou, G. A. (2018). Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies. The Journal of Antimicrobial Chemotherapy, 73(suppl_1), i60–i72. -
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial
Winston, D. J., Mullane, K. M., Cornely, O. A., Boeckh, M. J., Brown, J. W., Pergam, S. A., … Arvin, A. (2018). Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. LANCET, 391(10135), 2116–27. -
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Marty, F. M., Ljungman, P., Chemaly, R. F., Maertens, J., Dadwal, S. S., Duarte, R. F., … Badshah, C. (2017). Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 377(25), 2433–44. -
Treatment of Severe Acyclovir-Resistant Herpes Simplex Virus Infection with Continuous Infusion of High Dose Acyclovir Following Hematopoietic Cell Transplantation
Kim, J. H., Schaenman, J., Ho, D. Y., & Brown, J. (W. M. (2009). Treatment of Severe Acyclovir-Resistant Herpes Simplex Virus Infection with Continuous Infusion of High Dose Acyclovir Following Hematopoietic Cell Transplantation. BLOOD. AMER SOC HEMATOLOGY. -
Tolerability of Foscarnet As a Continuous Infusion for Treatment of Herpesvirus Infections
Brown, J. (W. M., Chang, A., Lee-Lam, F.-ying, Tan, S. K., & Shashidhar, S. (2014). Tolerability of Foscarnet As a Continuous Infusion for Treatment of Herpesvirus Infections. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(2), S191–S192. -
Rate of Rise of EBV Viral Load By Quantitative PCR after Allogeneic Transplantation Correlates with PTLD Facilitates Timely Institution of Rituximab
Muffly, L. S., Shiraz, P., Nguyen, I. T., & Brown, J. (W. M. (2016). Rate of Rise of EBV Viral Load By Quantitative PCR after Allogeneic Transplantation Correlates with PTLD Facilitates Timely Institution of Rituximab. BLOOD. AMER SOC HEMATOLOGY. -
Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy
Ravandi, F., Abboud, C. N., Akard, L. P., Gill, S. I., Hsu, J. W., Kambhampati, S., … Solh, M. (2018). Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy. BLOOD, 132. -
Pharmacokinetic-Pharmacodynamic Analyses to Provide Rezafungin Prophylaxis Dose Selection for Prevention of Invasive Fungal Infections for Bone Marrow Transplant Patients
Lakota, E. A., Flanagan, S., Sandison, T., Brown, J. W., & Rubino, C. M. (2018). Pharmacokinetic-Pharmacodynamic Analyses to Provide Rezafungin Prophylaxis Dose Selection for Prevention of Invasive Fungal Infections for Bone Marrow Transplant Patients. BLOOD, 132. -
Voriconazole for salvage treatment of invasive aspergillosis
Schlamm, H. T., Corey, L., Brown, J., & Perfect. (2000). Voriconazole for salvage treatment of invasive aspergillosis. CLINICAL INFECTIOUS DISEASES. UNIV CHICAGO PRESS. -
Effective containment of human respiratory syncytial virus infections in a bone marrow transplantation program resulting from the combined implementation of molecular epidemiology, infection control, and early treatment strategies.
Cha, S. S., Stuart, M. J., Poutanen, S., Madison, S., Baron, E. J., Erdman, D., & Brown, J. M. (2004). Effective containment of human respiratory syncytial virus infections in a bone marrow transplantation program resulting from the combined implementation of molecular epidemiology, infection control, and early treatment strategies. BLOOD, 104(11), 611A–612A. -
Improved Survival of High Risk Patients with Parainfluenza Virus Following Hematopoietic Cell Transplantation: Role of Aerosolized Ribavirin
Nguyen, I. T., Shashidhar, S., & Brown, J. (W. M. (2016). Improved Survival of High Risk Patients with Parainfluenza Virus Following Hematopoietic Cell Transplantation: Role of Aerosolized Ribavirin. BLOOD, 128(22). -
Common lymphoid progenitors from MHC-mismatched donors engraft without inducing GVHD.
Arber, C., BitMansour, A., & Brown, J. M. (2003). Common lymphoid progenitors from MHC-mismatched donors engraft without inducing GVHD. BLOOD, 102(11), 951A. -
Cryopreserved Ex Vivo-Expanded Allogeneic Myeloid Progenitor Cell Product Protects Neutropenic Mice From a Lethal Fungal Infection
Domen, J., Christensen, J. L., Gille, D., Smith-Berdan, S., Fong, T., Brown, J. M. Y., & Sedello, A. K. (2016). Cryopreserved Ex Vivo-Expanded Allogeneic Myeloid Progenitor Cell Product Protects Neutropenic Mice From a Lethal Fungal Infection. CELL TRANSPLANTATION, 25(1), 17–33. -
Phase 1 Clinical Investigation of Human Myeloid Progenitor Cells (CLT-008) As a Supportive Care Measure during Chemotherapy for Acute Myeloid Leukemia (AML)
Wieduwilt, M. J., Cerny, J., Akard, L., Ustun, C., Ravandi, F., Rossetti, J. M., … Andreadis, C. (2014). Phase 1 Clinical Investigation of Human Myeloid Progenitor Cells (CLT-008) As a Supportive Care Measure during Chemotherapy for Acute Myeloid Leukemia (AML). BLOOD. AMER SOC HEMATOLOGY. -
MHC-mismatched marine committed myeloid progenitors engraft and protect against invasive aspergillosis.
Arber, C., BitMansour, A., & Brown, J. M. (2003). MHC-mismatched marine committed myeloid progenitors engraft and protect against invasive aspergillosis. BLOOD, 102(11), 941A. -
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Chemaly, R. F., Ullmann, A. J., Stoelben, S., Richard, M. P., Bornhaeuser, M., Groth, C., … Ehninger, G. (2014). Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 370(19), 1781–89. -
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants
Mauskopf, J., Chirila, C., Graham, J., Gersten, I. D., Leather, H., Maziarz, R. T., … Wingard, J. R. (2013). Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 70(17), 1518–27. -
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., … Marr, K. A. (2010). Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. BLOOD, 116(24), 5111–18. -
Eremothecium coryli bloodstream infection in a patient with acute myeloid leukemia: first case report of human infection.
Multani, A., Rustagi, A., Epstein, D. J., Gomez, C. A., Budvytiene, I., Banaei, N., … Liu, A. Y. (2019). Eremothecium coryli bloodstream infection in a patient with acute myeloid leukemia: first case report of human infection. Diagnostic Microbiology and Infectious Disease. -
Eremothecium coryli bloodstream infection in a patient with acute myeloid leukemia: first case report of human infection
Multani, A., Rustagi, A., Epstein, D. J., Gomez, C. A., Budvytiene, I., Banaei, N., … Liu, A. Y. (2019). Eremothecium coryli bloodstream infection in a patient with acute myeloid leukemia: first case report of human infection. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 95(1), 77–79. -
Pharmacokinetic-pharmacodynamic analyses of dose selection for rezafungin prophylaxis against invasive fungal infections in blood and marrow transplantation
Brown, J., Lakota, E. A., Flanagan, S., Sandison, T., Ong, V., & Rubino, C. M. (2019). Pharmacokinetic-pharmacodynamic analyses of dose selection for rezafungin prophylaxis against invasive fungal infections in blood and marrow transplantation. BONE MARROW TRANSPLANTATION, 54, 430. -
Incidence and Impact of Cytomegalovirus in Hematopoietic Cell Transplant Recipients at a Single Center over the Last Decade
Johnsrud, J. J., Nguyen, I. T., Domingo, W., Tang, Y., Raval, A., & Brown, J. (W. (2020). Incidence and Impact of Cytomegalovirus in Hematopoietic Cell Transplant Recipients at a Single Center over the Last Decade. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), S346–S347. -
Letermovir Prophylaxis in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant
Nguyen, I. T., Johnsrud, J. J., Brown, J. (W., & Domingo, W. (2020). Letermovir Prophylaxis in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), S347–S348. -
Letermovir Prophylaxis Decreases Burden of CMV in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant.
Johnsrud, J. J., Nguyen, I. T., Domingo, W., Narasimhan, B., Efron, B., & Brown, J. W. (2020). Letermovir Prophylaxis Decreases Burden of CMV in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. -
Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency
Agarwal, R., Dvorak, C. C., Kwon, H.-S., Long-Boyle, J. R., Prohaska, S. S., Brown, J. W., … Shizuru, J. A. (2019). Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency. BLOOD. AMER SOC HEMATOLOGY.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects »
- A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) »
- Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi »
- Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis »
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001) »
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) »
- Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients »
- Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients »
Practice Locations
Blood and Marrow Transplant Program (BMT) - 900 Blake Wilbur Drive Palo Alto, CA
Palo Alto, CABlood and Marrow Transplant Program (BMT) - 900 Blake Wilbur Drive
900 Blake Wilbur Drive, 2nd Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records